Literature DB >> 7590867

Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation.

C Patry1, A Herbelin, A Lehuen, J F Bach, R C Monteiro.   

Abstract

The functional capacity of the human monocyte receptor for the Fc portion of IgA (Fc alpha R) in mediating signal transduction was evaluated by cytokine release. F(ab')2 fragments of anti-Fc alpha R monoclonal antibodies (mAb) were used as specific probes to induce release of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). Multivalent cross-linking by a secondary anti-mouse antibody [F(ab')2 fragments] induced a significant release of TNF-alpha and IL-6 by human blood mononuclear cells, indicating requirements for Fc alpha R aggregation on the cell surface to transmit signals. Both cytokines were released exclusively by adherent cells, identifying monocytes as the responding cells within the mononuclear cell population. This cytokine release could not be due to contaminating endotoxins, because it was not abolished by polymyxin B, a lipopolysaccharide (LPS) inhibitor. Moreover, purified recombinant soluble Fc alpha R inhibited the anti-Fc alpha R mAb-mediated cytokine release from blood monocytes, demonstrating that TNF-alpha and IL-6 were released in a receptor-specific manner. Our data suggest that Fc alpha R, through its capacity to mediate secretion of IL-6, may play an important role in B-cell proliferation and immunoglobulin production. On the other hand, release of TNF-alpha following stimulation of Fc alpha R molecules directly implicates these receptors in amplification and regulation of the inflammatory process occurring during IgA-mediated host defence.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590867      PMCID: PMC1383802     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  32 in total

Review 1.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

2.  Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase.

Authors:  J M Debets; J G Van de Winkel; J L Ceuppens; I E Dieteren; W A Buurman
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

3.  Cross-linking Fc receptors on monocytes triggers IL-6 production. Role in anti-CD3-induced T cell activation.

Authors:  J Krutmann; R Kirnbauer; A Köck; T Schwarz; E Schöpf; L T May; P B Sehgal; T A Luger
Journal:  J Immunol       Date:  1990-09-01       Impact factor: 5.422

4.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

Review 5.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

6.  My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function.

Authors:  L Shen; R Lasser; M W Fanger
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

7.  Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients.

Authors:  B Grossetête; J P Viard; A Lehuen; J F Bach; R C Monteiro
Journal:  AIDS       Date:  1995-03       Impact factor: 4.177

8.  Characterization of the IgA receptor from human polymorphonuclear leucocytes.

Authors:  M Albrechtsen; G R Yeaman; M A Kerr
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

9.  Immunofluorescence analysis of IgA binding by human mononuclear cells in blood and lymphoid tissue.

Authors:  A Chevailler; R C Monteiro; H Kubagawa; M D Cooper
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

10.  Cellular distribution, regulation, and biochemical nature of an Fc alpha receptor in humans.

Authors:  R C Monteiro; H Kubagawa; M D Cooper
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Diversity and duplicity: human FCgamma receptors in host defense and autoimmunity.

Authors:  Robert P Kimberly; Jianming Wu; Andrew W Gibson; Kaihong Su; Hongwe Qin; Xiaoli Li; Jeffrey C Edberg
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Cytokine responses of human blood monocytes stimulated with Igs.

Authors:  J L Foreback; D G Remick; E Crockett-Torabi; P A Ward
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

3.  Immunomodulatory properties of human serum immunoglobulin A: anti-inflammatory and pro-inflammatory activities in human monocytes and peripheral blood mononuclear cells.

Authors:  K Olas; H Butterweck; W Teschner; H P Schwarz; B Reipert
Journal:  Clin Exp Immunol       Date:  2005-06       Impact factor: 4.330

4.  Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cells.

Authors:  Virginie Pascal; Brice Laffleur; Arnaud Debin; Armelle Cuvillier; Marjolein van Egmond; Daniel Drocourt; Laurent Imbertie; Céline Pangault; Karin Tarte; Gérard Tiraby; Michel Cogné
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941

5.  A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.

Authors:  Maria T Ochoa; Rosane Teles; Blake E Haas; Danny Zaghi; Huiying Li; Euzenir N Sarno; Thomas H Rea; Robert L Modlin; Delphine J Lee
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

6.  Nasal immunization with Burkholderia multivorans outer membrane proteins and the mucosal adjuvant adamantylamide dipeptide confers efficient protection against experimental lung infections with B. multivorans and B. cenocepacia.

Authors:  Gustavo M Bertot; Marcela A Restelli; Laura Galanternik; Rene C Aranibar Urey; Miguel A Valvano; Saúl Grinstein
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

7.  The generation and evaluation of recombinant human IgA specific for Plasmodium falciparum merozoite surface protein 1-19 (PfMSP1 19).

Authors:  Jianguo Shi; Richard S McIntosh; Jaime Adame-Gallegos; Prabhjyot K Dehal; Marjolein van Egmond; Jan van de Winkel; Simon J Draper; Emily K Forbes; Patrick H Corran; Anthony A Holder; Jenny M Woof; Richard J Pleass
Journal:  BMC Biotechnol       Date:  2011-07-22       Impact factor: 2.563

8.  Elevated Membrane and Soluble CD64: A Novel Marker Reflecting Altered FcγR Function and Disease in Early Rheumatoid Arthritis That Can Be Regulated by Anti-Rheumatic Treatment.

Authors:  Peter Matt; Ulla Lindqvist; Sandra Kleinau
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

9.  Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora.

Authors:  Sergueï O Fetissov; Maria Hamze Sinno; Moïse Coëffier; Christine Bole-Feysot; Philippe Ducrotté; Tomas Hökfelt; Pierre Déchelotte
Journal:  Nutrition       Date:  2008-02-08       Impact factor: 4.008

10.  BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes.

Authors:  Sylwia Wasiak; Kim E Dzobo; Brooke D Rakai; Yannick Kaiser; Miranda Versloot; Mahnoush Bahjat; Stephanie C Stotz; Li Fu; Michael Sweeney; Jan O Johansson; Norman C W Wong; Erik S G Stroes; Jeffrey Kroon; Ewelina Kulikowski
Journal:  Clin Epigenetics       Date:  2020-11-11       Impact factor: 6.551

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.